COMMUNIQUÉS West-GlobeNewswire
-
Karamedica Announces National Institute of Aging Grant to Develop Microparticle Therapy for Cerebral Amyloid Angiopathy (CAA)
10/10/2018 - 14:00 -
Aeglea BioTherapeutics to Present New Interim Phase 1/2 Clinical Trial Data in Arginase 1 Deficiency at 2018 ASHG Annual Meeting
10/10/2018 - 14:00 -
PepsiCo and Loop Industries Sign Multi-Year Supply Agreement for Loop Branded 100% Sustainable Plastic
10/10/2018 - 14:00 -
VIVUS to Present at the BIO Investor Forum on October 17, 2018
10/10/2018 - 13:30 -
Amedisys Signs Definitive Agreement to Acquire Compassionate Care Hospice
10/10/2018 - 13:30 -
Marinus Pharmaceuticals Names Dr. Rolando Gutíerrez-Esteinou as VP of Clinical Development and Pharmacovigilance
10/10/2018 - 13:30 -
Moleculin Announces New Data Discovery Confirming Significant Increase in Potential to Starve Cancerous Tumors
10/10/2018 - 13:30 -
Pacific Biosciences Announces a New Paradigm in DNA Sequencing – Highly Accurate Single-Molecule Long Reads
10/10/2018 - 13:30 -
Helix BioPharma Corp. and Moffitt Cancer Center extend collaboration on immunotherapy, including study of L-DOS47 with PD-1/PD-L1 inhibitors
10/10/2018 - 13:30 -
VitalHub Announces Rebranding and Launch of Sri Lanka Innovations Lab
10/10/2018 - 13:30 -
CURE Pharmaceutical to Present at CannX 2018 International Medical Cannabis Conference
10/10/2018 - 13:25 -
Aleafia, Serruya Family Extend Exclusivity Period for Retail and Brand Joint-Venture
10/10/2018 - 13:05 -
Myriad Announces New Laboratory Agreement with Pfizer®
10/10/2018 - 13:05 -
Akorn Receives Product Approval
10/10/2018 - 13:05 -
Acarix AB enters strategic alliance with MED Management to broaden the commercial platform toward the German outpatient market
10/10/2018 - 13:01 -
Canopy Rivers Announces Significant Increase in Health Canada Licensed Infrastructure at Vert Mirabel
10/10/2018 - 13:00 -
Summit Therapeutics to Participate in Upcoming Investor Events
10/10/2018 - 13:00 -
Natus Medical to Hold 2018 Third Quarter Financial Results Conference Call on October 24th
10/10/2018 - 13:00 -
RedHill Biopharma Late-Breaking Abstract on Positive Phase III Crohn’s Disease Study with RHB-104 to be Presented at UEG Week 2018
10/10/2018 - 13:00
Pages